Answer
In cancer patients taking Akynzeo, netupitant has an apparent mean elimination half-life of 88 hours following a single dose, while palonosetron has a terminal elimination half-life of 48 ± 19 hours (mean ± SD).
Sources for this answer
- Akynzeo 300mg/0.5mg hard capsulesChugai Pharma UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 8Document updated
Sources checked